Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2023
Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directionsRiah Patterson, Irina Balan, A Leslie Morrow, et al.The Journal of Clinical Psychiatry|March 23, 2026
Temporal Dynamics of Antidepressant Response Following Brexanolone Treatment in Postpartum DepressionRachel Kozik, Riah Patterson, Elizabeth Andersen, et al.Annual Review of Medicine|November 11, 2024
Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant DepressionElizabeth Richardson, Riah Patterson, Samantha Meltzer-Brody, et al.Journal of the Academy of Consultation-Liaison Psychiatry|August 26, 2021
A Brexanolone Treatment Program at an Academic Medical Center: Patient Selection, 90-Day Posttreatment Outcomes, and Lessons LearnedRiah Patterson, Holly Krohn, Erin Richardson, et al.General Hospital Psychiatry|November 6, 2025
Open-label study of the efficacy, safety and tolerability of Brexanolone in the treatment of adult women with postpartum psychosisRiah Patterson, Holly Krohn, Elizabeth Richardson, et al.Journal of the Academy of Consultation-Liaison Psychiatry|March 6, 2025
Zuranolone for Postpartum Depression After Highly Lethal Suicide Attempt: Two Case Illustrations and a Narrative Literature ReviewAnne Ruminjo, Parisa R Kaliush, Emily M Pisetsky, et al.Ebiomedicine|February 21, 2023
Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathwaysIrina Balan, Riah Patterson, Giorgia Boero, et al.Translational Psychiatry|January 31, 2026
Brexanolone infusion produces sustained anti-inflammatory and neurotrophic effects in patients with postpartum depression that predict symptom improvementIrina Balan, Cecilia Isabel Sousa Pearson, Holly Krohn, et al.Pageof 1